Zobrazeno 1 - 10
of 189
pro vyhledávání: '"J. J. Rossi"'
Autor:
J. J. Rossi, J. Zhou
Publikováno v:
Advances in Nucleic Acid Therapeutics ISBN: 9781788012096
Rapid progress in sequencing technology has revealed a number of disease-related genes that are “undruggable” by conventional pharmaceuticals. Nucleic acid-based therapeutics offer an exclusive power to target the undruggable human and viral geno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e68af2496e8e43a75f991fe6d226a763
https://doi.org/10.1039/9781788015714-00266
https://doi.org/10.1039/9781788015714-00266
Autor:
K V, Morris, J J, Rossi
Publikováno v:
RNA Towards Medicine
RNA interference is a natural mechanism by which small interfering (si)RNA operates to specifically and potently down-regulate the expression of a target gene. This down-regulation has been thought to predominantly function at the level of the messen
Autor:
J J, Rossi
Publikováno v:
Current opinion in molecular therapeutics. 1(3)
During the past decade major advances have been made in combating HIV infection and reducing the incidence of AIDS in the western world. Despite optimism about such progress, there is accumulating evidence to suggest that new forms of therapy may be
Autor:
A, Michienzi, J J, Rossi
Publikováno v:
Methods in enzymology. 341
Publikováno v:
Journal of molecular biology. 303(4)
The binding of human immunodeficiency virus type 1 (HIV-1) Rev protein to its viral RNA target, stem-loop IIB (SLIIB) within the Rev Response element (RRE), mediates the export of singly-spliced and unspliced viral mRNA from the nucleus to the cytopl
Autor:
J J Rossi
Publikováno v:
Gene Therapy. 16:579-580
Publikováno v:
Methods in enzymology. 313
Autor:
J J Rossi
Publikováno v:
Gene Therapy. 13:1493-1494
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 3(4)
The bcr-abl oncogene is the molecular counterpart of the Philadelphia chromosome (Ph), which is detected in95% of patients with chronic myelogenous leukemia (CML) and 20-30% of adults with acute lymphoblastic leukemia (ALL). Leukemic cells from patie
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 74